Company
Garuda develops proprietary hematopoietic stem cell therapies that enable self-renewing
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Garuda Therapeutics | Series A | 2025-03-04 | Lead |
Company
| Company | Round | Date | Lead |
|---|---|---|---|
| Garuda Therapeutics | Series A | 2025-03-04 | Lead |